Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
Supporting Files
Public Domain
-
August 2018
-
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:Progressive multifocal leukoencephalopathy (PML) is increasingly being reported in patients undergoing immunotherapy. We report a case of progressive multifocal leukoencephalopathy after treatment with nivolumab, a PD-1 blocker that is used to restore impaired T-cell responses in patients with cancer and infections. Data for 4 other cases were obtained from pharmacovigilance databases.
-
Subjects:
-
Source:Emerg Infect Dis. 24(8):1594-1596
-
Pubmed ID:30016251
-
Pubmed Central ID:PMC6056118
-
Document Type:
-
Genre:
-
Volume:24
-
Issue:8
-
Collection(s):
-
Main Document Checksum:urn:sha256:063d5cdef19967f75ac7e2c46f356e3ab5066f8c4084508ae852f829da1ae82d
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases